Liezl Gambe

Santos (ASX:STO) has commenced continuous production at its Alaskan oil project, initially delivering 20,000 barrels per day.

Toss Bank, South Korea's third-largest internet-only bank, signed a memorandum of understanding with Solana (CRYPTO:SOL) to test stablecoin-powered cross-border remittance infrastructure for its approximately 15 million customers.

Calix (ASX:CXL), through its Leilac subsidiary, signed an agreement with Ambuja Cements to develop a low-carbon cement project in India.

ASIC proposes a five-year extension for four key financial services relief instruments to maintain market certainty.

INVO Fertility (NASDAQ:IVF) recorded a 23% increase in year-over-year revenue to $2.02 million for the first quarter of 2026.

Biopharmaceutical firm Nuvectis (NASDAQ:NVCT) licensed exclusive ex-China rights for two clinical drug assets in a deal valued up to $1.461 billion.

Organon (NYSE:OGN) finalized a global licensing agreement with Sebela Pharmaceuticals for a hormone-free birth control device that is 99% effective.

Definium Therapeutics (NASDAQ:DFTX) stated its depression drug trial succeeded, showing a key 8.1-point improvement over a placebo.

Baker Hughes (NASDAQ:BKR) is discussing potential commitments with the European Commission to clear its acquisition of Chart Industries (NYSE:GTLS).

Getty Images (NYSE:GETY) signed a multi-year display partnership to bring its licensed content libraries directly into OpenAI's ChatGPT.